Michael Mallek, MD, is a professor and the director of the Center of Integrated Oncology at the University of Cologne and University of Bonn, Germany.
Prof. Hallek received his medical degree in 1985 from the University of Munich, Germany. He then continued his education in pharmacology and internal medicine at the University and Technical University of Munich, Germany, until 1990. Afterwards, he worked for two years at the Dana Farber Cancer Institute, Boston, MA, as a research associate. On his return to Germany, Prof. Hallek specialized in hematology oncology. He then worked as the head of the Gene Therapy Program at the Gene Center of the University of Munich until 2005.
Speaking on CLL, the role of the microenvironment and novel therapies
At his research lab in Cologne, Germany, Prof. Mallek leads research focused on the mechanisms that trigger the development of leukemia. Specifically, the team looks at the role of the microenvironment and the specific pathways involved in its communication to leukemic cells. They hope that their research can lead to the development of novel ideas that can be used therapeutically.